 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Metalloprotease
|
PDB id
|
|
|
|
1ayk
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.7
- Interstitial collagenase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Cleaves preferentially one bond in native collagen. Cleavage of the triple helix of collagen at about three-quarters of the length of the molecule from the N-terminus, at 775-Gly-|-Ile-776 in the alpha-1(I) chain. Cleaves synthetic substrates and alpha-macroglobulins at bonds where P1' is a hydrophobic residue.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zinc
|
 |
 |
 |
 |
 |
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular matrix
|
1 term
|
 |
|
Biological process
|
proteolysis
|
1 term
|
 |
|
Biochemical function
|
metallopeptidase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
37:1495-1504
(1998)
|
|
PubMed id:
|
|
|
|
|
| |
|
High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR.
|
|
F.J.Moy,
P.K.Chanda,
S.Cosmi,
M.R.Pisano,
C.Urbano,
J.Wilhelm,
R.Powers.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The high-resolution solution structure of the inhibitor-free catalytic fragment
of human fibroblast collagenase (MMP-1), a protein of 18.7 kDa, which is a
member of the matrix metalloproteinase family, has been determined using
three-dimensional heteronuclear NMR spectroscopy. A total of 30 structures were
calculated by means of hybrid distance geometry-simulated annealing using a
total of 3333 experimental NMR restraints, consisting of 2409 approximate
interproton distance restraints, 84 distance restraints for 42 backbone hydrogen
bonds, 426 torsion angle restraints, 125 3JNH alpha restraints, 153 C alpha
restraints, and 136 C beta restraints. The atomic rms distribution about the
mean coordinate positions for the 30 structures for residues 7-137 and 145-163
is 0.42 +/- 0.04 A for the backbone atoms, 0.80 +/- 0.04 A for all atoms, and
0.50 +/- 0.03 A for all atoms excluding disordered side chains. The overall
structure of MMP-1 is composed of a beta-sheet consisting of five beta-strands
in a mixed parallel and anti-parallel arrangement and three alpha-helices. A
best-fit superposition of the NMR structure of inhibitor-free MMP-1 with the
1.56 A resolution X-ray structure by Spurlino et al. [Spurlino, J. C.,
Smallwood, A. M., Carlton, D. D., Banks, T. M., Vavra, K. J., Johnson, J. S.,
Cook, E. R., Falvo, J., and Wahl, R. C., et al. (1994) Proteins: Struct.,
complexed with a hydroxamate inhibitor yields a
backbone atomic rms difference of 1.22 A. The majority of differences between
the NMR and X-ray structure occur in the vicinity of the active site for MMP-1.
This includes an increase in mobility for residues 138-144 and a displacement
for the Ca(2+)-loop (residues 74-80). Distinct differences were observed for
side-chain torsion angles, in particular, the chi 1 for N80 is -60 degrees in
the NMR structure compared to 180 degrees in the X-ray. This results in the side
chain of N80 occupying and partially blocking access to the active site of MMP-1.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.D.Durrant,
C.A.de Oliveira,
and
J.A.McCammon
(2010).
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.
|
| |
J Mol Recognit, 23,
173-182.
|
 |
|
|
|
|
 |
R.Bhaskaran,
M.O.Palmier,
N.A.Bagegni,
X.Liang,
and
S.R.Van Doren
(2007).
Solution structure of inhibitor-free human metalloelastase (MMP-12) indicates an internal conformational adjustment.
|
| |
J Mol Biol, 374,
1333-1344.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.P.Todorov,
C.L.Buenemann,
and
I.L.Alberts
(2006).
De novo ligand design to an ensemble of protein structures.
|
| |
Proteins, 64,
43-59.
|
 |
|
|
|
|
 |
Y.J.Huang,
R.Tejero,
R.Powers,
and
G.T.Montelione
(2006).
A topology-constrained distance network algorithm for protein structure determination from NOESY data.
|
| |
Proteins, 62,
587-603.
|
 |
|
|
|
|
 |
A.Láng,
I.G.Csizmadia,
and
A.Perczel
(2005).
Peptide models XLV: conformational properties of N-formyl-L-methioninamide and its relevance to methionine in proteins.
|
| |
Proteins, 58,
571-588.
|
 |
|
|
|
|
 |
I.Bertini,
V.Calderone,
M.Cosenza,
M.Fragai,
Y.M.Lee,
C.Luchinat,
S.Mangani,
B.Terni,
and
P.Turano
(2005).
Conformational variability of matrix metalloproteinases: beyond a single 3D structure.
|
| |
Proc Natl Acad Sci U S A, 102,
5334-5339.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Powers,
N.Mirkovic,
S.Goldsmith-Fischman,
T.B.Acton,
Y.Chiang,
Y.J.Huang,
L.Ma,
P.K.Rajan,
J.R.Cort,
M.A.Kennedy,
J.Liu,
B.Rost,
B.Honig,
D.Murray,
and
G.T.Montelione
(2005).
Solution structure of Archaeglobus fulgidis peptidyl-tRNA hydrolase (Pth2) provides evidence for an extensive conserved family of Pth2 enzymes in archea, bacteria, and eukaryotes.
|
| |
Protein Sci, 14,
2849-2861.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
X.Huang,
F.Moy,
and
R.Powers
(2000).
Evaluation of the utility of NMR structures determined from minimal NOE-based restraints for structure-based drug design, using MMP-1 as an example.
|
| |
Biochemistry, 39,
13365-13375.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
|